EX-16.1 7 ff12021ex16-1_neurosense.htm LETTER FROM ERAN YAHALOM, CPA

Exhibit 16.1

 

 

Eran Yahalom, CPA

Nahal Ayalon St. 20, Tzur Yitzhak, Israel

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 

October 15th, 2021

 

Commissioners:

 

I have read the statements made by NeuroSense Therapeutics Ltd. under the caption “Change in Accountants” included in its Registration Statement on Form F-1. I agree with the statements concerning our firm in such Form F-1.

 

Very truly yours,    
     
/s/ Eran Yahalom, CPA    
     
    Eran Yahalom, CPA
     
    /s/ Eran Yahalom, CPA
   

 

 

 

050   9889966   eran@eycpa.co.il   www.eycpa.co.il